CRXM — Gene Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Gene Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2016 December 31st	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.93	0.049	0.082	0	0.386
Total Inventory
Prepaid Expenses
Total Current Assets	0.941	0.074	0.101	0.033	0.411
Net Property, Plant And Equipment	0.158	0.124	0.061	0.003	0.149
Long Term Investments
Other Long Term Assets
Total Assets	1.11	0.21	0.162	0.035	0.567
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.39	5.36	5.79	4.76	5.03
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	4.25	5.01	5.32	4.33	4.44
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-3.14	-4.8	-5.16	-4.29	-3.88
Total Liabilities & Shareholders' Equity	1.11	0.21	0.162	0.035	0.567
Total Common Shares Outstanding
Total Preferred Shares Outstanding